Register July 2018 No. 751
Chapter Phar 1
AUTHORITY AND DEFINITIONS
Ch. Phar 1 Note
Note: Chapter Phar 1 as it existed on January 31, 1983 was repealed and a new chapter Phar 1 was created effective February 1, 1983.
Phar 1.01 History
History: Cr.
Register, January, 1983, No. 325, eff. 2-1-83; am.
Register, August, 1991, No. 428, eff. 9-1-91; am.,
Register, December, 1998, No. 516, eff. 1-1-99; am.,
Register, March, 2000, No. 531, eff. 4-1-00;
correction made under s. 13.93 (2m) (b) 7., Stats.,
Register January 2002 No. 553;
CR 17-090: am. Register July 2018 No. 751, eff. 8-1-18. Phar 1.02(1)
(1) “Board" means the pharmacy examining board.
Phar 1.02 Note
Note: The board office is located at 1400 East Washington Avenue, Madison, Wisconsin 53702.
Phar 1.02(2)
(2) “Community pharmacy" means practice in a licensed pharmacy providing pharmaceutical services primarily on an outpatient basis.
Phar 1.02(3)
(3) “DEA" means the drug enforcement administration.
Phar 1.02(4)
(4) “Institutional pharmacy" means practice in a licensed pharmacy providing pharmaceutical services primarily on an inpatient basis.
Phar 1.02(6)
(6) “Managing pharmacist" means a pharmacist designated by the pharmacy owner to have responsibility for and direct control of pharmaceutical operations in a pharmacy.
Phar 1.02(6m)
(6m) “NABP” means the National Association of Boards of Pharmacy.
Phar 1.02(7)
(7) “NAPLEX" means the North American Pharmacy Licensing Examination.
Phar 1.02(9)
(9) “Pharmacist-in-charge" means a pharmacist who is physically present in the licensed facility and responsible for the routine operation of a pharmacy for the period of time specified by the managing pharmacist.
Phar 1.02(10)
(10) “Pharmacy” means any place of practice licensed by the board under s.
450.06 or
450.065, Stats., unless otherwise provided for in s.
450.065, Stats.
Phar 1.02(11)
(11) “Pharmacy owner" means a person or entity to whom a pharmacy license is issued.
Phar 1.02(14)
(14) “Professional service area" means the area of a pharmacy in which prescriptions are compounded or dispensed, hypodermic needles, syringes, poisons and schedule V controlled substances as listed in s.
961.22, Stats., and ch.
CSB 2 are available, or where patients are consulted.
Phar 1.02(15)
(15) “Terminal illness" means an incurable condition caused by injury or illness that reasonable medical judgment finds would cause death.
Phar 1.02 History
History: Cr.
Register, January, 1983, No. 325, eff. 2-1-83; am. (intro.), renum. (2) to (9) to be (6) to (12) and (14) and am. (8), (10) and (12), cr. (2) to (5) and (13),
Register, August, 1991, No. 428, eff. 9-1-91; cr. (4m) and (15),
Register, September, 1994, No. 465, eff. 10-1-94; am. (7), (8), (11) and (14),
Register, December, 1998, No. 516, eff. 1-1-99; am. (intro.),
Register, March, 2000, No. 531, eff. 4-1-00;
emerg. cr. (3c), (4c), (4e), and (14m), eff. 1-1-02
; correction in (intro.) made under s. 13.93 (2m) (b) 7., Stats.,
Register January 2002 No. 553;
CR 14-023: am. (7)
Register August 2014 No. 704, eff. 9-1-14;
CR 15-064: am. (10)
Register September 2016 No. 729, eff. 10-1-16;
CR 16-017: cr. (6m)
Register September 2016 No. 729, eff. 10-1-16; correction in (10) made under s. 35.17, Stats.,
Register September 2016 No. 729;
2017 Wis. Act 18: am. (4m)
Register June 2017 No. 738, eff. July 1, 2017;
CR 17-090: am. (intro.) Register July 2018 No. 751, eff. 8-1-18.